CCM
RMD icon

Cinctive Capital Management’s ResMed RMD Stock Holding History

Cinctive Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,000
Closed -$7.28M – 619
2022
Q1 		$7.28M Buy
+30,000
New +$7.26M 0.27% 120

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Cinctive Capital Management's RMD Position: Q3 2021 in Review

Cinctive Capital Management sold out of ResMed (RMD) in Q3 2021, closing a stake of 4,868 shares — an estimated $1.2M sold.

Cinctive Capital Management first reported a position in RMD in Q2 2021 and held it in 1 quarter. The position peaked at $1.2M in Q2 2021. 686 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

  • Cinctive Capital Management reported no remaining ResMed position as of Q3 2021 after selling out during the quarter.
  • Cinctive Capital Management sold 4,868 ResMed shares in Q3 2021, an estimated $1.2M.
  • Cinctive Capital Management first reported a position in ResMed in Q2 2021 and held it in 1 quarter.
  • Cinctive Capital Management's ResMed position peaked at $1.2M in Q2 2021.
  • 686 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on Cinctive Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.